Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to researchers in the Department of Oncology, who have received a number of prestigious awards this month.

Professor McKenna pictured giving his prize lecture.

The Department of Oncology is celebrating a number of awards and grants in the past month. 

Dr Bart Cornelissen of the CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology has secured a £200k grant from UK medical research charity, Pancreatic Cancer Research Fund (PCRF).

Dr James Larkin, a postdoctoral researcher from Nicola Sibson’s lab in the CRUK/MRC Oxford Institute for Radiation Biology, has won a silver medal in 2018 STEM for Britain, a Parliamentary poster competition that gives researchers the chance to present their work to policymakers and politicians and discuss their work with local MPs. 

Dr Xiao Wan from Professor Eric O’Neill’s group has been successful in obtaining an NC3Rs Training Fellowship for ‘Developing human organotypic perfused bioreactors for physiologically reproducible therapeutic compound screening of a tumour microenvironment’.

And finally, Professor Gillies McKenna, Director of the CRUK/MRC Oxford Institute for Radiation Oncology, is the recipient of the prestigious Breur Award for 2018. The award is named after Professor Klaas Breur, one of the founding fathers of ESTRO. As a tribute to Professor Breur’s pioneering work, ESTRO created an annual 'Gold Medal' award lecture in his name, which was delivered by Professor McKenna at the ESTRO Annual Meeting in Barcelona this month. The Breur Award is the highest honour that can be conferred on an ESTRO member and is awarded in recognition of the major contribution made by the winner to European radiotherapy.  

Congratulations to all researchers!

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.